Ph II Early BC Pre-Surgical Biologic Study
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gefitinib
Sponsor: AstraZeneca
Collaborators: Cancer International Research Group (CIRG)